Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Shelley Wood

April 29, 2020

Presentation TCT 2018

Use of ECMO during Cardiac Arrest: When and How, Complications and Outcomes

Presenter: Cindy L. Grines, E. Magnus Ohman, Sachin Kumar

September 22, 2018

Presentation TCT 2018

Use of ECMO in Cardiogenic Shock: When and How, Complications and Outcomes

Presenter: Cindy L. Grines, E. Magnus Ohman, A. Reshad Garan

September 22, 2018

Presentation TCT 2018

Use of Impella (CP and RP) in Cardiogenic Shock: From Hemodynamics to Clinical Outcomes

Presenter: Cindy L. Grines, E. Magnus Ohman, William W. O'Neill

September 22, 2018

Presentation TCT 2018

IABP in Cardiogenic Shock: Reconciling Clinical Trial Results and Guidelines With Real-World Experience (With Practical-use Recommendations)

Presenter: Cindy L. Grines, E. Magnus Ohman, Richard Smalling

September 22, 2018

Presentation TCT 2018

Major Learnings From IABP-Shock II and CULPRIT-Shock

Presenter: Cindy L. Grines, E. Magnus Ohman, Holger Thiele

September 22, 2018

Presentation TCT 2018

Acute Cardiogenic Shock: Pathophysiology and Treatment Goals

Presenter: Cindy L. Grines, E. Magnus Ohman, Timothy D. Henry

September 22, 2018

Presentation TCT 2018

Defining Cardiogenic Shock: Update From the SCAI/HFSA Working Group

Presenter: Cindy L. Grines, E. Magnus Ohman, David A Baran

September 22, 2018

News Conference News ACC 2014

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Yael L. Maxwell

March 31, 2014

Advertisement

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Use of ECMO during Cardiac Arrest: When and How, Complications and Outcomes

Use of ECMO in Cardiogenic Shock: When and How, Complications and Outcomes

Use of Impella (CP and RP) in Cardiogenic Shock: From Hemodynamics to Clinical Outcomes

IABP in Cardiogenic Shock: Reconciling Clinical Trial Results and Guidelines With Real-World Experience (With Practical-use Recommendations)

Major Learnings From IABP-Shock II and CULPRIT-Shock

Acute Cardiogenic Shock: Pathophysiology and Treatment Goals

Defining Cardiogenic Shock: Update From the SCAI/HFSA Working Group

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content